Microbot Medical signs three-year exclusive distribution deal with Medtechnica in Israel for LIBERTY system
MBOT•Microbot Medical signed a three-year exclusive deal for Medtechnica to market and sell its LIBERTY endovascular robotic system in Israel. The system received Israeli Ministry of Health AMAR clearance and was registered in May 2026; initial orders are expected in Q4 2026.
1. Israel distribution deal
Microbot Medical signed a three-year exclusive distribution deal with Medtechnica to market and sell the LIBERTY endovascular robotic system in Israel. The deal follows Israeli Ministry of Health AMAR clearance, and LIBERTY was registered in the AMAR medical device registry in May 2026. Initial orders from Medtechnica are expected in Q4 2026.
